TABLE 2.
12 continuous health outcomes | HannumEAA (s.d. = 3.63 years) | IEAA (s.d. = 3.69 years) | PhenoEAA (s.d. = 4.79 years) | GrimEAA (s.d. = 3.43 years) | DunedinPACE (s.d. = 0.1064) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Spearman’s correlation | 95% CI | p-value | Spearman’s correlation | 95% CI | p-value | Spearman’s correlation | 95% CI | p-value | Spearman’s correlation | 95% CI | p-value | Spearman’s correlation | 95% CI | p-value | ||||||
Body mass index | 0.089 | 0.050 | 0.128 | 9.8E-06 | 0.058 | 0.019 | 0.098 | 3.7E-03 | 0.115 | 0.076 | 0.154 | 1.1E-08 | 0.115 | 0.076 | 0.154 | 1.0E-08 | 0.238 | 0.200 | 0.275 | 4.1E-33 |
Body fat percentage | 0.084 | 0.044 | 0.124 | 3.7E-05 | 0.046 | 0.006 | 0.086 | 2.3E-02 | 0.101 | 0.061 | 0.140 | 7.9E-07 | 0.104 | 0.064 | 0.144 | 3.6E-07 | 0.217 | 0.178 | 0.255 | 7.8E-27 |
Waist circumference | 0.084 | 0.044 | 0.123 | 3.2E-05 | 0.048 | 0.009 | 0.087 | 1.7E-02 | 0.106 | 0.066 | 0.144 | 1.5E-07 | 0.110 | 0.071 | 0.149 | 4.1E-08 | 0.209 | 0.171 | 0.247 | 8.4E-26 |
Fasting glucose | −0.011 | −0.051 | 0.028 | 5.8E-01 | −0.025 | −0.064 | 0.015 | 2.2E-01 | −0.029 | −0.069 | 0.010 | 1.5E-01 | −0.049 | −0.088 | −0.010 | 1.5E-02 | −0.109 | −0.148 | −0.070 | 5.3E-08 |
HbA1c | 0.014 | −0.026 | 0.053 | 4.9E-01 | −0.010 | −0.050 | 0.029 | 6.2E-01 | 0.014 | −0.026 | 0.053 | 4.9E-01 | 0.003 | −0.037 | 0.042 | 8.9E-01 | −0.019 | −0.059 | 0.020 | 3.4E-01 |
Diastolic blood pressure | 0.026 | −0.013 | 0.066 | 1.9E-01 | 0.056 | 0.017 | 0.095 | 5.4E-03 | 0.025 | −0.015 | 0.064 | 2.2E-01 | 0.007 | −0.032 | 0.047 | 7.2E-01 | 0.017 | −0.022 | 0.057 | 3.9E-01 |
Systolic blood pressure | 0.026 | −0.013 | 0.066 | 1.9E-01 | 0.031 | −0.009 | 0.070 | 1.3E-01 | 0.011 | −0.029 | 0.050 | 5.9E-01 | 0.017 | −0.023 | 0.056 | 4.1E-01 | 0.023 | −0.017 | 0.062 | 2.6E-01 |
Triglyceride | 0.020 | −0.020 | 0.059 | 3.3E-01 | −0.008 | −0.048 | 0.031 | 6.8E-01 | 0.027 | −0.013 | 0.066 | 1.9E-01 | −0.014 | −0.053 | 0.026 | 5.0E-01 | 0.026 | −0.013 | 0.066 | 1.9E-01 |
LDL-C | −0.016 | −0.055 | 0.024 | 4.3E-01 | −0.016 | −0.055 | 0.024 | 4.4E-01 | −0.023 | −0.062 | 0.017 | 2.6E-01 | −0.009 | −0.049 | 0.030 | 6.5E-01 | −0.039 | −0.079 | 0.000 | 5.1E-02 |
HDL-C | −0.043 | −0.082 | −0.003 | 3.5E-02 | −0.013 | −0.052 | 0.027 | 5.3E-01 | −0.039 | −0.078 | 0.001 | 5.4E-02 | −0.068 | −0.107 | −0.029 | 7.0E-04 | −0.131 | −0.170 | −0.092 | 6.5E-11 |
TG/HDL-C ratio | 0.029 | −0.010 | 0.069 | 1.5E-01 | −0.009 | −0.048 | 0.031 | 6.6E-01 | 0.035 | −0.005 | 0.074 | 8.5E-02 | −0.022 | −0.061 | 0.018 | 2.8E-01 | 0.029 | −0.011 | 0.068 | 1.6E-01 |
Forced vital capacity | −0.020 | −0.069 | 0.030 | 4.3E-01 | −0.003 | −0.052 | 0.046 | 9.1E-01 | 0.004 | −0.045 | 0.054 | 8.6E-01 | −0.004 | −0.054 | 0.045 | 8.7E-01 | −0.003 | −0.053 | 0.046 | 8.9E-01 |